MDT vs REGN: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

MDT
Medtronic plc
BUY
80%
Confidence
VS
REGN
REGENERON PHARMACEUTICALS, INC.
BUY
80%
Confidence

MDT vs REGN Fundamental Comparison

Metric MDT REGN
Revenue $26.6B $14.3B
Net Income $3.6B $4.5B
Net Margin 13.4% 31.4%
ROE 7.3% 14.4%
ROA 3.9% 11.1%
Current Ratio 2.54x 4.13x
Debt/Equity 0.57x 0.06x
EPS $2.76 $41.48

Green = Better metric | Red = Weaker metric

View Full MDT Analysis →
View Full REGN Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

MDT vs AAPL REGN vs MSFT MDT vs GOOGL REGN vs AMZN

MDT vs REGN: Frequently Asked Questions

Is MDT or REGN a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. MDT is rated BUY (80% confidence) while REGN is rated BUY (80% confidence). This is not investment advice.

How does MDT compare to REGN fundamentally?

Medtronic plc has ROE of 7.3% vs REGENERON PHARMACEUTICALS, INC.'s 14.4%. Net margins are 13.4% vs 31.4% respectively.

Which stock pays higher dividends, MDT or REGN?

MDT has a dividend yield of N/A or no dividend while REGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in MDT or REGN for long term?

For long-term investing, consider that MDT has BUY rating with 80% confidence, while REGN has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about MDT vs REGN?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDT vs REGN, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.